Meeting
2021 ASCO Annual Meeting
Machine learning-based multiple cancer detections with circulating miRNA profiles in the blood.
Authors
Juntaro Matsuzaki
Division of Pharmacotherapeutics, Keio University Faculty of Pharmacy, Tokyo, Japan
Juntaro Matsuzaki , Yusuke Yamamoto , Ouyang Yi , Sandeep Ayyar , Ryo Miyajima , Yutaka Takeda , Timothy Nolan , Nobuhiro Kawai , Ken Kato , Nobuyuki Ota , Takahiro Ochiya
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Track
Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology
Sub Track
Circulating Biomarkers
Citation
J Clin Oncol 39, 2021 (suppl 15; abstr 3037)
DOI
10.1200/JCO.2021.39.15_suppl.3037
Abstract #
3037
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Identification and validation of a serum microRNA panel for detection of early-stage breast cancer.
First Author: Ruiyang Zou
Poster
2024 ASCO Annual Meeting
Adopting combination machine learning models could reduce hospital length of stay for oncology patients.
First Author: Srisairam Achuthan
Poster
2023 ASCO Breakthrough
i-Biomarker CaDx: A circulating miRNA-based multi-cancer detection tool with explainable AI for breast cancer.
First Author: Alexandru George Floares
Poster
2023 ASCO Annual Meeting
Using machine learning to characterize lung cancer microenvironment and the development of a model to predict the presence of similar microenvironment in other cancers.
First Author: Ahmad Charifa